Mobile Narcotic Treatment Programs and Medication Units Round Two

Overview

The primary objective of this funding opportunity is to expand the availability of MUs and MNTPs, to increase MOUD access for rural areas, justice-involved populations, Indigenous and Native communities, patients without transportation, and areas that do not have a Narcotic Treatment Program (NTP) within close proximity to patients in need of NTP services. MUs and MNTPs expand access to medications for opioid use disorder treatment (MOUD, also known as MAT), including buprenorphine, methadone, and naltrexone, to patients unable to travel to an NTP due to lack of geographic proximity or other factors. On June 28, 2021, the U.S. Drug Enforcement Administration (DEA) released new rules allowing DEA-registered Opioid Treatment Programs (NTPs in California) to establish and operate MNTPs...